FindTrial
Sign In

A retrospective study on residual pancreatic surveillance after pancreatic tumor resection

A retrospective study on residual pancreatic surveillance after pancreatic tumor resection - residual pancreatic cancer surveillance

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000052738
Enrollment
132
Registered
2023-11-09
Start date
2023-11-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Sponsors

Shimane University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cases who underwent pancreatic resection between April 2012 and March 2023 and were diagnosed with pancreatic cancer or intraductal papillary mucinous tumor.

Exclusion criteria

Exclusion criteria: 1) Case after total pancreatectomy 2) Cases where medical information is unclear

Design outcomes

Primary

MeasureTime frame
Development of residual pancreatic cancer—

Countries

Japan

Contacts

Public ContactNobuhiko Fukuba

Shimane University Internal medicine II

nfukuba@med.shimane-u.ac.jp0853202111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026